Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Maze Therapeutics (MAZE) Tax Provisions (2024)

Maze Therapeutics has reported Tax Provisions over the past 1 years, most recently at -$275000.0 for Q4 2024.

  • Quarterly Tax Provisions changed N/A to -$275000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$275000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $1.2 million for FY2024, N/A changed from the prior year.
  • Tax Provisions was -$275000.0 for Q4 2024 at Maze Therapeutics, up from -$279000.0 in the prior quarter.
  • Over five years, Tax Provisions peaked at $1.7 million in Q2 2024 and troughed at -$279000.0 in Q3 2024.